Can robotic surgery match open surgery in beating cervical cancer?
NCT ID NCT03719547
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial asks whether robot-assisted hysterectomy is as effective as traditional open surgery for treating early-stage cervical cancer. About 800 women with stage IB (excluding IB3) or IIA1 cervical cancer will be randomly assigned to one of the two surgical approaches. The main goal is to compare how long women remain free of cancer recurrence after surgery. The study also tracks overall survival and surgical complications to help guide future treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Robot-assisted radical hysterectomy (compared to open abdominal radical hysterectomy)
- What this could lead to
- If robot-assisted surgery proves as effective as open surgery, it could offer a less invasive option with similar cancer control for early-stage cervical cancer.
- What could go wrong
- The trial is large but results are not yet available; robot-assisted surgery may not match open surgery in preventing recurrence, and there are risks of surgical complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karolinska University Hospital
RECRUITINGStockholm, 17176, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a Two-Antibody combo outsmart advanced cancer?
- Blood test clues could sharpen cervical cancer treatment
- Can a new drug rally the immune system against Hard-to-Treat cancers?